Suchergebnisse - "Yao, Hang-Ping"

PubPharm (11)

1

Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer

enthalten in: Biochimica et biophysica acta. Reviews on cancer | 2020

von Yao, H. | Hudson, R. | Wang, M.

2

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma : molecular features as drug targets and antibody-drug conjugates for therapy

enthalten in: Journal of experimental & clinical cancer research : CR | 2020

von Yao, H. | Tong, X. | Hudson, R. | +1

3

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular features as drug targets and antibody-drug conjugates for therapy

enthalten in: Journal of experimental & clinical cancer research | 2020

von Yao, H. | Tong, X. | Hudson, R. | +1

4

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular features as drug targets and antibody-drug conjugates for therapy

enthalten in: Journal of experimental & clinical cancer research | 2020

von Yao, H. | Tong, X. | Hudson, R. | +1

5

RON receptor tyrosine kinase in pancreatic ductal adenocarcinoma : Pathogenic mechanism in malignancy and pharmaceutical target for therapy

enthalten in: Biochimica et biophysica acta. Reviews on cancer | 2020

von Yao, H. | Hudson, R. | Wang, M.

6

Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer

enthalten in: Journal of experimental & clinical cancer research : CR | 2016

von Feng, L. | Yao, H. | Zhou, Y. | +3

ErratumIn: J Exp Clin Cancer Res. 2016;35(1):95. - PMID 27316712

7

Therapeutic evaluation of monoclonal antibody-maytansinoid conjugate as a model of RON-targeted drug delivery for pancreatic cancer treatment

enthalten in: American journal of cancer research | 2016

von Yao, H. | Feng, L. | Zhou, J. | +2

8

Prevention of BMS-777607-induced polyploidy/senescence by mTOR inhibitor AZD8055 sensitizes breast cancer cells to cytotoxic chemotherapeutics

enthalten in: Molecular oncology | 2014

von Sharma, S. | Yao, H. | Zhou, Y. | +3

9

Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase

enthalten in: Cancer chemotherapy and pharmacology | 2010

von Guin, S. | Ma, Q. | Padhye, S. | +3

10

Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase

enthalten in: Cancer chemotherapy and pharmacology | 2010

von Guin, S. | Ma, Q. | Padhye, S. | +3